in
Address: Oxfordlaan 70, Maastricht, See on map
Founded: 2008
Categories: Medical
Investor(s): Biopartner br>
0
The company, FABPulous BV, will deal with the production and sale of a rapid diagnostic test within a few moments a heart attack will be able to demonstrate or exclude. It is expected that the heart attack test FABPulous at the end of 2008 commercially available. The name is derived from the marker used in this test is used: Fatty Acid-Binding Protein, or FABP.
Javascript is required to view this map.